Posts tagged Edelweiss
Latest Research Reports On Stocks By Leading Brokerages: If you have any research reports that you would like to share with us, please send it to michael@rakesh-jhunjhunwala.in or to admin@rakesh-jhunjhunwala.in. (The pre-June 2016 reports are available here).
| Adani Ports Is One Of The Best Infra Plays: Edelweiss Research Report | |
| Company: | Adani Ports |
| Brokerage: | Edelweiss |
| Date of report: | May 4, 2021 |
| Type of Report: | Result Update |
| Recommendation: | Buy |
| Upside Potential: | 15% |
| Summary: | Strong show across ports; port margin touches 70% |
| Full Report: | Click here to view full post with link to download pdf file |
| Tags: | Adani Ports |
| Tactical BUY Recommendation Of PNC Infratech Ltd By Edelweiss For 60% Upside Gain | |
| Company: | PNC Infratech |
| Brokerage: | Edelweiss |
| Date of report: | April 27, 2021 |
| Type of Report: | Initiating Coverage |
| Recommendation: | Buy |
| Upside Potential: | 60% |
| Summary: | PNC’s strengths – stable NWC, low leverage and high RoCE |
| Full Report: | Click here to view full post with link to download pdf file |
| Tags: | PNC Infratech |
| Top 5 Pharma Stocks To Buy Now: Edelweiss Research Report | |
| Company: | Model Portfolio, Sun Pharma |
| Brokerage: | Edelweiss |
| Date of report: | April 12, 2021 |
| Type of Report: | Model Portfolio |
| Recommendation: | Buy |
| Upside Potential: | 22% |
| Summary: | SUN PHARMA entering into an earnings upgrade cycle |
| Full Report: | Click here to view full post with link to download pdf file |
| Tags: | 5 Best Pharma Stocks, Model Portfolio |
| Vinati Organics Ltd Research Report By Edelweiss | |
| Company: | Vinati Organics |
| Brokerage: | Edelweiss |
| Date of report: | April 9, 2021 |
| Type of Report: | Result Update |
| Recommendation: | Buy |
| Upside Potential: | 21% |
| Summary: | Refuelling for next leg of growth |
| Full Report: | Click here to view full post with link to download pdf file |
| Tags: | Vinati Organics |
| Balaji Amines Ltd: Research Report By Edelweiss | |
| Company: | Balaji Amines |
| Brokerage: | Edelweiss |
| Date of report: | February 11, 2021 |
| Type of Report: | Result Update |
| Recommendation: | Buy |
| Upside Potential: | 17% |
| Summary: | Phenomenal show – outlook robust with strong capex pipeline |
| Full Report: | Click here to view full post with link to download pdf file |
| Tags: | Balaji Amines |
| PSP Projects Ltd Research Report By Edelweiss | |
| Company: | PSP Projects Ltd |
| Brokerage: | Edelweiss |
| Date of report: | February 5, 2021 |
| Type of Report: | Result Update |
| Recommendation: | Buy |
| Upside Potential: | 52% |
| Summary: | New order wins lead to earning upgrades |
| Full Report: | Click here to view full post with link to download pdf file |
| Tags: | PSP Projects Ltd |
| Kolte Patil Developers Ltd (Mohnish Pabrai High-Conviction Portfolio Stock) Research Report By Edleweiss | |
| Company: | Kolte-Patil Developers |
| Brokerage: | Edelweiss |
| Date of report: | January 10, 2021 |
| Type of Report: | Initiating Coverage |
| Recommendation: | Buy |
| Upside Potential: | 17% |
| Summary: | Scaling up for next leg of growth |
| Full Report: | Click here to view full post with link to download pdf file |
| Tags: | Kolte-Patil Developers |
| City Union Bank Research Report By Edelweiss | |
| Company: | City Union Bank |
| Brokerage: | Edelweiss |
| Date of report: | December 23, 2020 |
| Type of Report: | Initiating Coverage |
| Recommendation: | Buy |
| Upside Potential: | 42% |
| Summary: | A bankable play! |
| Full Report: | Click here to view full post with link to download pdf file |
| Tags: | City Union Bank |
| Pidilite: Buy Recommendation By Edelweiss | |
| Company: | Pidilite |
| Brokerage: | Edelweiss |
| Date of report: | December 11, 2020 |
| Type of Report: | Result Update |
| Recommendation: | Buy |
| Upside Potential: | 14.74% |
| Summary: | Araldite buy: Perfect growth glue |
| Full Report: | Click here to view full post with link to download pdf file |
| Tags: | Pidilite |
| Glenmark Pharmaceuticals Ltd: Edelweiss Research Report | |
| Company: | Glenmark Pharma |
| Brokerage: | Edelweiss |
| Date of report: | December 7, 2020 |
| Type of Report: | Result Update |
| Recommendation: | Buy |
| Upside Potential: | 11% |
| Summary: | API external sales were strong. As customers look to diversify away from China, expects the API business to continue to post strong growth |
| Full Report: | Click here to view full post with link to download pdf file |
| Tags: | Glenmark Pharma |